263 results match your criteria: "Quebec Heart Institute[Affiliation]"
Europace
May 2021
Division of Cardiology, Department of Medicine, University of Calgary, Libin Cardiovascular Institute, Calgary, AB, Canada.
Aims: Post-operative pain following cardiac implantable electronic device (CIED) insertion is associated with patient dissatisfaction, emotional distress, and emergency department visits. We sought to identify factors associated with post-operative pain and develop a prediction score for post-operative pain.
Methods And Results: All patients from the BRUISE CONTROL-1 and 2 trials were included in this analysis.
Europace
July 2020
Southlake Regional Health Centre, 602-581 Davis Drive, Newmarket, ON L3Y 2P6, Canada.
Aims: Atrial fibrillation (AF) significantly impairs patients' quality of life (QOL). We performed this study to investigate the effect of AF-ablation success and atrial fibrillation burden (AFB) on QOL measures.
Methods And Results: Overall, 230 patients with paroxysmal AF refractory to antiarrhythmic drugs were enrolled and underwent ablation in a multicentre, prospective cohort.
Eur Heart J
August 2020
Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Secondary mitral regurgitation and secondary tricuspid regurgitation due to heart failure (HF) remain challenging in almost every aspect: increasing prevalence, poor prognosis, notoriously elusive in diagnosis, and complexity of therapeutic management. Recently, defined HF subgroups according to three ejection fraction (EF) ranges (reduced, mid-range, and preserved) have stimulated a structured understanding of the HF syndrome but the role of secondary valve regurgitation (SVR) across the spectrum of EF remains undefined. This review expands this structured understanding by consolidating the underlying phenotype of myocardial impairment with each type of SVR.
View Article and Find Full Text PDFCirc Arrhythm Electrophysiol
October 2019
Department of Medicine, University of Ottawa, University of Ottawa Heart Institute, ON, Canada (P.B.N., G.A.W., D.H.B.).
Background: Oral anticoagulant use is common among patients undergoing pacemaker or defibrillator surgery. BRUISE CONTROL (Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial; NCT00800137) demonstrated that perioperative warfarin continuation reduced clinically significant hematomas (CSH) by 80% compared with heparin bridging (3.5% versus 16%).
View Article and Find Full Text PDFBackground: Pulmonary vein isolation by catheter ablation is a class IA indication for the treatment of symptomatic, drug-refractory, paroxysmal atrial fibrillation (PAF). Quality of life (QoL) has been identified as a clinically meaningful endpoint but has not been comprehensively evaluated to date.
Objective: The purpose of this study was to evaluate the effects of cryoballoon ablation on long-term QoL.
Pacing Clin Electrophysiol
July 2019
Southlake Regional Health Centre, Newmarket, Ontario, Canada.
Background: Multipolar phased pulmonary vein ablation catheter (PVAC), specifically its second-generation (PVAC-Gold), has been associated with reduced procedural time for atrial fibrillation (AF) ablation compared to traditional catheters. We performed this study to compare the efficacy of PVAC with point-by-point radiofrequency (RF) ablation.
Methods: This is a multicenter-cohort study (2012-2017), involving patients with symptomatic, paroxysmal AF refractory to at least one antiarrhythmic medication.
JACC Clin Electrophysiol
March 2019
Massachusetts General Hospital, Boston, Massachusetts.
Objectives: STOP AF PAS (Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study) is the first prospective, multicenter, 3-year study in North America to assess long-term safety and effectiveness of the cryoballoon for treatment of patients with drug-refractory symptomatic pAF.
Background: The STOP AF PAS was required by the U.S.
JACC Basic Transl Sci
February 2018
NaviGate Cardiac Structures, Inc., Lake Forest, California.
Patients with isolated functional or recurrent tricuspid regurgitation are often denied surgery because they are considered to be at high risk. Transcatheter valve therapy provides a less invasive alternative for tricuspid regurgitation associated with right heart failure. We have evaluated the feasibility of transcatheter tricuspid valve implantation of the NaviGate valved stent in a long-term swine model.
View Article and Find Full Text PDFAnn Noninvasive Electrocardiol
September 2015
Division of Cardiology, Institute of Clinical Medicine, University of Oulu, and University Hospital of Oulu, Finland.
Background: Patients with diabetes mellitus (DM) have a higher risk of sudden cardiac death. Factors associated with the risk profiles of coronary artery disease (CAD) patients with DM are not well established. Heart rate turbulence (HRT) and T-wave alternans (TWA) are often used to predict arrhythmia events.
View Article and Find Full Text PDFHeart Rhythm
March 2015
University of British Columbia, Vancouver, British Columbia, Canada.
Background: Cable externalization and insulation abrasion are known to occur with the St Jude Medical Riata leads under advisory. The distribution of these abnormalities and how they relate to clinical presentation have not been well described.
Objective: In this study, we sought to determine the relationship between structural lead failure and clinical presentation by using the analysis of returned Riata products in Canada.
Arch Cardiol Mex
February 2015
Quebec Heart Institute and Lung Institute, Laval University, Quebec City, Quebec, Canada.
Eur Heart J
July 2014
Population Health Research Institute, McMaster-University-Hamilton Health Sciences, Hamilton, ON, Canada.
Aims: We studied the unclear question whether blood pressure (BP) lowering reduces cardiovascular disease (CVD) in elderly individuals with systolic BP <160 mm Hg.
Methods And Results: We initiated a randomized placebo-controlled stratified 2 × 2 factorial clinical trial evaluating the effects of BP lowering in 11 000 elderly individuals with systolic blood pressure (SBP) between 130 and 159 mm Hg, for 5 years. Following 5-week active run-in, participants were randomized to aliskiren (300 mg) or placebo, and to an additional antihypertensive [hydrochlorothiazide (25 mg) or amlodipine (5 mg)], or their respective placeboes.
Cardiology
May 2012
Laboratoire d'Études Moléculaires des Valvulopathies, Groupe de Recherche en Valvulopathies, Quebec Heart Institute/Hôpital Laval Research Center, Department of Surgery, Laval University, 2725 Chemin Ste-Foy, Québec, QC, Canada.
Objectives: Long-term durability of bioprosthetic heart valves (BPs) are limited by structural valve degeneration (SVD) leading to stenosis and/or regurgitation. In this study, we sought to determine the metabolic markers associated with SVD.
Methods: In a cohort of 220 patients with an aortic BP (mean follow-up of 2.
Cardiology
December 2011
Laboratoire d'Études Moléculaires des Valvulopathies, Groupe de Recherche en Valvulopathies, Laval Hospital Research Center/Quebec Heart Institute, Department of Surgery, Laval University, Québec City, Qué., Canada.
Objectives: Adiponectin is a protein secreted by adipocytes which has anti-inflammatory properties. The objective of this study was to examine the relationship between adiponectinemia and the hemodynamic progression of aortic stenosis (AS) as well as the degree of inflammation in the valve explanted at the time of aortic valve replacement (AVR).
Methods: The plasma level of adiponectin was measured in 122 patients undergoing AVR.
The angiotensin-converting enzyme (ACE) gene is a candidate genetic locus for coronary artery disease (CAD). Studies investigating the relationship between the ACE-insertion/deletion (I/D) gene polymorphism and myocardial infarction (MI) have been inconsistent. The authors hypothesized that age may be an important modulating factor in this relationship.
View Article and Find Full Text PDFCirc Cardiovasc Interv
December 2008
Quebec Heart Institute/Laval Hospital, 2725 Chemin Ste-Foy, Quebec, Canada.
J Thorac Cardiovasc Surg
July 2010
Quebec Heart Institute and Lung Institute, Laval University, Quebec City, Quebec, Canada.
J Thorac Cardiovasc Surg
October 2009
Quebec Heart Institute, Laval Hospital, Québec, Canada.
Int J Cardiol
December 2010
Laboratoire d'Études Moléculaires des Valvulopathies (LEMV), Laval Hospital Research Center/Quebec Heart Institute, Department of Surgery, Laval University, Québec, Canada.
Introduction: The progression of aortic stenosis (AS) has been shown to be faster in patients with the metabolic syndrome. We sought to determine the relationships between blood pressure, inflammation, oxidative stress and valvular inflammation in a population of normotensive and prehypertensive patients with AS.
Methods: In this study, 36 male patients (age: 61.
Obesity (Silver Spring)
October 2009
Division of Kinesiology, Department of Social and Preventive Medicine, Faculty of Medicine, Laval University, and Quebec Heart Institute, Hôpital Laval Research Center, Quebec City, Quebec, Canada.
The aim of this study was to determine the independent contribution of previously reported risk factors for adult overweight and obesity. A cross-sectional (n=537) and a longitudinal (n=283; 6-year follow-up period) analysis was performed for nine risk factors for overweight and obesity assessed in adult participants (aged 18-64 years) of the Quebec Family Study (QFS). The main outcome measure was overweight/obesity, defined as a BMI>or=25 kg/m2.
View Article and Find Full Text PDFAm J Cardiol
April 2009
Interventional Cardiology Laboratories, Quebec Heart Institute-Laval Hospital, Quebec, Canada.
The objectives of this study were to evaluate the usefulness of fractional flow reserve (FFR) measurements to guide the clinical decision in patients with intermediate left main coronary artery (LMCA) stenosis and to determine the predictors of major adverse cardiac events (MACE) -- cardiac death, myocardial infarction, coronary revascularization -- in such cases; 142 consecutive patients with intermediate LMCA stenosis (mean percent diameter stenosis 42 +/- 13%) were included. All patients underwent FFR measurement after intracoronary administration of adenosine at a dose > or =30 microg. The clinical decisions were based on FFR as follows: coronary revascularization was recommended if FFR was <0.
View Article and Find Full Text PDFAm J Clin Nutr
May 2009
Québec Heart Institute, Hôpital Laval Research Centre, Hôpital Laval, Québec, Canada.
Background: C-reactive protein (CRP) concentrations have been found to be higher in premenopausal women than in men, whereas interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) concentrations have been reported to be lower in women than in men.
Objective: The objective was to determine whether the sex difference in body fat distribution accounts for the observed sex differences in inflammatory markers.
Design: Plasma CRP, IL-6, and TNF-alpha concentrations were measured in 208 healthy men (age: 42.
Can J Cardiol
March 2009
Department of Cardiology, Quebec Heart Institute, Laval Hospital, Quebec City, Canada.
A 74-year-old man presented for shortness of breath. Echocardiography revealed the presence of a large pericardial effusion with signs of tamponade. A right atrial mass was suspected and later confirmed by transesophageal echocardiography.
View Article and Find Full Text PDFCirculation
March 2009
Quebec Heart Institute/Laval Hospital, Laval University, Quebec City, Canada.
Circulation
February 2009
Department of Medicine, Laval Hospital Research Center/Québec Heart Institute, Laval University, 2725 Chemin Sainte-Foy, Québec, Canada.